Patients tested, n | Abnormal test result, % (95% CI) | False positive rate*, % (95% IC) | Positive likelihood ratio (95% IC) | |
---|---|---|---|---|
Motor response ≤ 2 | ||||
- 24 h-36 h | 97 | 87% [80% - 93%] | 56% [45%- 67% | 1.7 [1.2 - 2.5] |
- 72 h | 87 | 70% [61% - 80%] | 16% [7% - 25%] | 5.8 [2.3 -1 4.1] |
No corneal reflexes | ||||
- 24 h-36 h | 95 | 40% [30% - 50%] | 12% [2% - 22%] | 4.2 [1.4 - 12.4] |
- 72 h | 86 | 36% [26% - 46%] | 0% [0%-14%] | 26 [1.7 - 415] |
No pupillary reflexes | ||||
- 24 h-36 h | 97 | 26% [17% - 35%] | 4% [4% - 12%] | 8.3 [1.2 - 58] |
- 72 h | 87 | 21% [12% - 29%] | 0% [0% - 14%] | 15 [1 - 244] |
Myoclonus | ||||
- 24 h-36 h | 97 | 27% [18% - 36%] | 0% [0% -14%] | 19 [1.2 - 299] |
- 72 h | 87 | 23% [14% - 32%] | 8% [4% - 20%] | |
Epilepsy | ||||
- 24 h-36 h | 97 | 7% [7% - 12%] | 0% [0% -14%] | 5.3 [0.3-90] |
- 72 h | 87 | 7% [2% - 12%] | 0% [0% -14%] | 5.3 [0.31-91] |
- Malignant EEG ** | ||||
- 24-36 h | 90 ¶ | 44% [34% - 55%] | 4% [2% - 10%] | 14 [2.1-97] |
- 72 h | 73¶¶ | 44% [33% - 55%] | 0% [0% -17%] | 25 [1.6-394] |
Highest measurement of NSE ≥ 47 ng/mL | ||||
97 | 58% [48% - 68%] | 7% [0,4% - 14%] | 4.5 [1.8 -11] | |
Highest measurement of NSE ≥ 97 ng/mL | ||||
97 | 36% [27% - 46%] | 0% [0% -13%] | 25 [1.6-397] |